Literature DB >> 21846220

Predictors of HVOT performance in Parkinson's disease.

Christopher I Higginson1, Vicki L Wheelock, Dawn Levine, Conrad T E Pappas, Karen A Sigvardt.   

Abstract

Evidence suggests that the Hooper Visual Organization Test (HVOT) has naming and executive components that vary in size depending on neurological diagnosis. The current study used a sample of individuals with Parkinson's disease (PD) to demonstrate for the first time that an executive measure can be the best predictor of HVOT performance. Forty-eight nondemented and nondepressed individuals with idiopathic PD completed the HVOT and other measures of visuoperception, executive function, and visual confrontation naming. Despite average performance on all neuropsychological measures, an executive measure, time to complete Trail-Making Test Part B minus time to complete Part A, was clearly the best predictor of HVOT performance in a standard regression. The pattern of neurocognitive predictors is unlike that reported in healthy individuals and other patient samples. This finding suggests that the presence of a neuropathological process can alter neurocognitive correlates even when performance is intact, and supports the contention that executive function is paramount in the cognitive profile associated with PD.

Entities:  

Mesh:

Year:  2011        PMID: 21846220      PMCID: PMC3199217          DOI: 10.1080/09084282.2011.595447

Source DB:  PubMed          Journal:  Appl Neuropsychol        ISSN: 0908-4282


  31 in total

1.  Factor structure of the Hooper Visual Organization Test: a cross-cultural replication and extension.

Authors:  Thomas Merten
Journal:  Arch Clin Neuropsychol       Date:  2005-01       Impact factor: 2.813

2.  Investigating temporal lobe contribution to confrontation naming using MRI quantitative volumetrics.

Authors:  Michael Seidenberg; Elizabeth Geary; Bruce Hermann
Journal:  J Int Neuropsychol Soc       Date:  2005-07       Impact factor: 2.892

3.  Cognitive correlates of HVOT performance differ between individuals with mild cognitive impairment and normal controls.

Authors:  Angela L Jefferson; Sarah Wong; Elizabeth Bolen; Al Ozonoff; Robert C Green; Robert A Stern
Journal:  Arch Clin Neuropsychol       Date:  2006-08-08       Impact factor: 2.813

4.  Recognition memory in Parkinson's disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis.

Authors:  Christopher I Higginson; Vicki L Wheelock; Kimberly E Carroll; Karen A Sigvardt
Journal:  J Clin Exp Neuropsychol       Date:  2005-05       Impact factor: 2.475

5.  A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease.

Authors:  Maja Relja; Natasa Klepac
Journal:  J Neurol Sci       Date:  2006-06-22       Impact factor: 3.181

6.  Disturbances in higher function in Parkinson's disease.

Authors:  F Tamaru
Journal:  Eur Neurol       Date:  1997       Impact factor: 1.710

7.  Visuospatial dysfunction and problem solving in Parkinson's disease.

Authors:  A Cronin-Golomb; A E Braun
Journal:  Neuropsychology       Date:  1997-01       Impact factor: 3.295

Review 8.  Sensory and cognitive functions of the basal ganglia.

Authors:  L L Brown; J S Schneider; T I Lidsky
Journal:  Curr Opin Neurobiol       Date:  1997-04       Impact factor: 6.627

9.  Executive function in Parkinson's disease: set-shifting or set-maintenance?

Authors:  M Richards; L J Cote; Y Stern
Journal:  J Clin Exp Neuropsychol       Date:  1993-03       Impact factor: 2.475

10.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Authors:  A M Owen; M James; P N Leigh; B A Summers; C D Marsden; N P Quinn; K W Lange; T W Robbins
Journal:  Brain       Date:  1992-12       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.